Determination of glycated hemoglobin in clinically silent hemoglobin variants

Diabetes/metabolism Research and Reviews
Wolfgang J SchnedlRandie R Little

Abstract

Evaluation of glycated hemoglobin determination methods in patients with clinically silent hemoglobin variants. HbA1c results were determined with various methods, including a new enzymatic assay, a boronate affinity HPLC, immunoassays and ion-exchange HPLC in patients with the clinically silent hemoglobin variants Hb Graz, Hb Sherwood Forest, Hb D and Hb O Padova. The effect of hemoglobin variants on glycated hemoglobin determination was method-dependent. The enzymatic and boronate affinity HPLC method did not interfere with any of the variants evaluated. In contrast, Hb Graz interfered with all immunoassay and ion-exchange HPLC methods evaluated. The Tosoh ion-exchange HPLC method HLC-723 did not detect the late migrating Hb O Padova in the chromatogram, but this hemoglobin variant still interfered causing artificially low HbA1c results. Our study underscores the need for clinical laboratories and physicians to be aware of the limitations of their HbA1c assay methods as well as the importance of visual inspection of ion-exchange chromatograms to detect abnormalities caused by the hemoglobin variants. Samples with clinically silent Hb variants should be analyzed by a second method with a different assay principle, preferably a...Continue Reading

References

Jun 27, 2000·Diabetes Care·R R Little
Apr 18, 2001·Diabetes/metabolism Research and Reviews·W J SchnedlG J Krejs
Aug 27, 2002·Journal of Clinical Pathology·T LahousenW J Schnedl
Feb 1, 2003·Clinical Chemistry·Ikunosuke SakurabayashiMasayuki Yagi
Jul 2, 2003·Diabetes Care·UNKNOWN American Diabetes Association
Jul 26, 2003·Clinical Chemistry·David B Sacks

❮ Previous
Next ❯

Citations

Jul 8, 2008·Clinical Chemistry and Laboratory Medicine : CCLM·Johannes M W van den OuwelandPiero C Giordano
Nov 18, 2008·Clinical Chemistry and Laboratory Medicine : CCLM·Erna Lenters-Westra, Robbert J Slingerland
May 16, 2008·The American Journal of the Medical Sciences·Sudip NandaMohammad I Arastu
Sep 3, 2008·Clinica Chimica Acta; International Journal of Clinical Chemistry·Wolfgang J SchnedlRainer W Lipp
Feb 12, 2008·Clinical Biochemistry·Limin LiuChong Yuan
Aug 23, 2005·Diabetes/metabolism Research and Reviews
Apr 4, 2008·International Journal of Laboratory Hematology·A AgorastiD Konstantinidou
Oct 2, 2015·Indian Journal of Endocrinology and Metabolism·Niharika YedlaAmbrish Mithal
Jul 18, 2008·Primary Care Diabetes·Viroj Wiwanitkit
Jan 5, 2010·The Korean journal of laboratory medicine·Chae Lim JungWha Soon Chung
Dec 19, 2018·Korean journal of family medicine·Ji Hyun YangAlice Hyun-Kyung Tan
Dec 21, 2018·BMJ Case Reports·Emily Finan, Joe Joseph
Sep 23, 2009·The Medical Journal of Australia·Goce DimeskiJacobus P J Ungerer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.